- Congress considered proposals to strengthen FDA authority regarding medical device regulation and minimum standards.
- Policymakers are considering ways to influence the drug market, including potential changes to patent rights and the FDA approval process.
Congress and the Senate are considering legislation affecting FDA submissions and drug patent rights.
1 report, 1 independent
Updated Oct 21
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Congress and the Senate are considering legislation affecting FDA submissions and drug patent rights.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
- FDA
-
Congress
US record label; imprint of Congress Record Corp.
- A trip involving Alaska and Arizona, congressional travel, and updates on key appointments like Brooke Rollins (Agriculture Secretary) and Bill Pulte (FHA Director).
- Political parties in Punjab, including AAP, BJP, and Congress, are defining their strategies and roles in the state's political future.
-
senate
type of legislative body, often the upper house or chamber of a bicameral legislature
Related events
- Litigation regarding FDA approval process.
- Eli Lilly and Company plans to submit a drug candidate to the FDA for review and approval.
- New FDA rule threatens the ability to import medicines.
- A company is conducting clinical trials and seeking drug approval for the U.S. market under the FDA.
- Lawsuits filed in Seattle involve FDA oversight, while the FDA investigates food safety issues in New Jersey.